Aspira Women's Health Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q4 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Aspira Women's Health Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q4 2024.
  • Aspira Women's Health Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 18, 2024 was 16.7M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 16.7M Nov 18, 2024 10-Q 2024-11-19
Q2 2024 16.1M +5.86M +57.5% Aug 9, 2024 10-Q 2024-08-13
Q1 2024 12.3M +4.01M +48.2% Mar 28, 2024 10-K 2024-04-01
Q3 2023 10.3M -114M -91.7% Nov 9, 2023 10-Q 2023-11-13
Q2 2023 10.2M -102M -90.9% Aug 10, 2023 10-Q 2023-08-14
Q1 2023 8.33M -104M -92.6% Mar 20, 2023 10-K/A 2023-10-26
Q3 2022 124M +12.3M +11% Nov 4, 2022 10-Q 2022-11-10
Q2 2022 112M +229K +0.21% Aug 5, 2022 10-Q 2022-08-10
Q1 2022 112M +422K +0.38% Mar 18, 2022 10-K 2022-03-31
Q3 2021 112M +8.04M +7.73% Nov 8, 2021 10-Q 2021-11-10
Q2 2021 112M +8.25M +7.94% Aug 9, 2021 10-Q 2021-08-12
Q1 2021 112M +14.4M +14.8% Mar 29, 2021 10-K 2021-03-31
Q3 2020 104M +6.85M +7.04% Oct 31, 2020 10-Q 2020-11-12
Q2 2020 104M +6.63M +6.82% Jul 31, 2020 10-Q 2020-08-14
Q1 2020 97.3M +21.8M +28.8% Mar 24, 2020 10-K 2020-04-07
Q3 2019 97.2M +21.9M +29% Oct 31, 2019 10-Q 2019-11-12
Q2 2019 97.2M +21.9M +29.1% Jul 31, 2019 10-Q 2019-08-08
Q1 2019 75.5M +15.5M +25.8% Mar 22, 2019 10-K 2019-03-28
Q3 2018 75.4M +15.4M +25.6% Oct 31, 2018 10-Q 2018-11-08
Q2 2018 75.3M +19.1M +34% Jul 31, 2018 10-Q 2018-08-09
Q1 2018 60M +3.95M +7.04% Mar 9, 2018 10-K 2018-03-13
Q3 2017 60M +7.73M +14.8% Oct 31, 2017 10-Q 2017-11-08
Q2 2017 56.2M +3.94M +7.55% Jul 31, 2017 10-Q 2017-08-11
Q1 2017 56.1M +3.98M +7.63% Mar 24, 2017 10-K 2017-03-31
Q3 2016 52.3M +259K +0.5% Oct 31, 2016 10-Q 2016-11-10
Q2 2016 52.2M +258K +0.5% Jul 29, 2016 10-Q 2016-08-10
Q1 2016 52.1M +9M +20.9% Mar 25, 2016 10-K 2016-03-30
Q3 2015 52M +16M +44.4% Oct 31, 2015 10-Q 2015-11-12
Q2 2015 52M +16.1M +44.8% Jul 31, 2015 10-Q 2015-08-13
Q1 2015 43.1M +7.28M +20.3% Mar 24, 2015 10-K 2015-03-31
Q3 2014 36M +12.5M +53.4% Oct 31, 2014 10-Q 2014-11-13
Q2 2014 35.9M +12.4M +52.8% Jul 31, 2014 10-Q 2014-08-14
Q1 2014 35.8M +20.6M +136% Apr 30, 2014 10-Q 2014-05-15
Q3 2013 23.5M +8.39M +55.6% Oct 31, 2013 10-Q 2013-11-14
Q2 2013 23.5M -131M -84.8% Jul 31, 2013 10-Q 2013-08-14
Q1 2013 15.2M +291K +1.95% Apr 30, 2013 10-Q 2013-05-15
Q3 2012 15.1M +239K +1.61% Oct 31, 2012 10-Q 2012-11-13
Q2 2012 154M +139M +940% Jul 31, 2012 10-Q 2012-08-14
Q1 2012 14.9M Apr 30, 2012 10-Q 2012-05-15
Q3 2011 14.9M Oct 31, 2011 10-Q 2011-11-09
Q2 2011 14.8M Jul 31, 2011 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.